Your browser doesn't support javascript.
loading
Rosiglitazone blocks first trimester in-vitro placental injury caused by NF-κB-mediated inflammation.
Kadam, Leena; Kilburn, Brian; Baczyk, Dora; Kohan-Ghadr, Hamid Reza; Kingdom, John; Drewlo, Sascha.
Afiliación
  • Kadam L; Department of Obstetrics & Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Kilburn B; Department of Obstetrics & Gynecology, Wayne State University School of Medicine, Detroit, MI, USA.
  • Baczyk D; The Research Centre for Women's and Infant's Health, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Kohan-Ghadr HR; Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA.
  • Kingdom J; The Research Centre for Women's and Infant's Health, Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
  • Drewlo S; Department of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, USA. Sascha.drewlo@hc.msu.edu.
Sci Rep ; 9(1): 2018, 2019 02 14.
Article en En | MEDLINE | ID: mdl-30765769

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Placenta / Primer Trimestre del Embarazo / FN-kappa B / Rosiglitazona Tipo de estudio: Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Placenta / Primer Trimestre del Embarazo / FN-kappa B / Rosiglitazona Tipo de estudio: Prognostic_studies Límite: Female / Humans / Pregnancy Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos